Skip To Content

 

Insights

Recent updates

 

Sharing perspectives leads to greater understanding and fuels innovation

Check out our latest updates:

July 18, 2023 · Clinical Team
The 2Q 2023 Brand-Generic Pipeline update Read more...
July 06, 2023 · Clinical Team
Extended-release Brixadi has been approved by the FDA for subcutaneous injection in patients recovering from Opioid Use Disorder as part of their treatment plan. Read more...
<< Previous     
Page 5 of 5